NEO
Price
$16.41
Change
+$0.01 (+0.06%)
Updated
Dec 20, 04:59 PM (EDT)
65 days until earnings call
VCYT
Price
$40.89
Change
+$1.82 (+4.66%)
Updated
Dec 20 closing price
71 days until earnings call
Ad is loading...

NEO vs VCYT

Header iconNEO vs VCYT Comparison
Open Charts NEO vs VCYTBanner chart's image
NeoGenomics
Price$16.41
Change+$0.01 (+0.06%)
Volume$8.9K
CapitalizationN/A
Veracyte
Price$40.89
Change+$1.82 (+4.66%)
Volume$2.01M
CapitalizationN/A
NEO vs VCYT Comparison Chart
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. VCYT commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Hold and VCYT is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (NEO: $16.41 vs. VCYT: $40.89)
Brand notoriety: NEO and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 445% vs. VCYT: 252%
Market capitalization -- NEO: $2.01B vs. VCYT: $1.66B
NEO [@Medical Specialties] is valued at $2.01B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • NEO’s TA Score: 5 bullish, 4 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NEO is a better buy in the short-term than VCYT.

Price Growth

NEO (@Medical Specialties) experienced а -7.45% price change this week, while VCYT (@Medical Specialties) price change was -5.39% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

NEO is expected to report earnings on Feb 25, 2025.

VCYT is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than VCYT($1.66B). VCYT YTD gains are higher at: 48.637 vs. NEO (1.422). NEO has higher annual earnings (EBITDA): -17.61M vs. VCYT (-49.41M). NEO has more cash in the bank: 415M vs. VCYT (216M). VCYT has less debt than NEO: VCYT (12.6M) vs NEO (612M). NEO has higher revenues than VCYT: NEO (592M) vs VCYT (361M).
NEOVCYTNEO / VCYT
Capitalization2.01B1.66B121%
EBITDA-17.61M-49.41M36%
Gain YTD1.42248.6373%
P/E Ratio49.50N/A-
Revenue592M361M164%
Total Cash415M216M192%
Total Debt612M12.6M4,857%
FUNDAMENTALS RATINGS
NEO vs VCYT: Fundamental Ratings
NEO
VCYT
OUTLOOK RATING
1..100
9092
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9189
PRICE GROWTH RATING
1..100
4838
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (40) in the Biotechnology industry is in the same range as NEO (71) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's SMR Rating (89) in the Biotechnology industry is in the same range as NEO (91) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's Price Growth Rating (38) in the Biotechnology industry is in the same range as NEO (48) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOVCYT
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWMIX21.070.25
+1.20%
CIBC Atlas Mid Cap Equity Institutional
JDMNX145.131.66
+1.16%
Janus Henderson Enterprise N
PAEAX19.520.14
+0.72%
Putnam Dynamic Asset Allocation Gr A
RMYCX9.140.04
+0.44%
Russell Inv Multi-Strategy Income C
VELIX16.69-1.02
-5.77%
VELA Large Cap Plus I

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with FLGT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+0.06%
FLGT - NEO
49%
Loosely correlated
-2.19%
VCYT - NEO
43%
Loosely correlated
+4.66%
RGEN - NEO
43%
Loosely correlated
-1.42%
BLFS - NEO
42%
Loosely correlated
+4.90%
AORT - NEO
40%
Loosely correlated
+1.82%
More